Home › Funds › Ghisallo Capital Management LLC › MLYS
Ghisallo Capital Management LLC position in MLYS
MINERALYS THERAPEUTICS INC · Health Care
Ghisallo Capital Management LLC reported holding 1,125,000 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$28.3M, representing 0.65% of its reported portfolio and ranking #24 among its reported holdings. Ghisallo Capital Management LLC has disclosed MLYS holdings in 3 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ghisallo Capital Management LLC's MLYS position evolved
Ghisallo Capital Management LLC first disclosed a stake in MLYS in Q3 2023 at 10,000 shares (US$95K). The position peaked in Q2 2026 at 1,125,000 shares, worth US$30.4M. Across 3 filings, Ghisallo Capital Management LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,125,000 shares valued at US$28.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 10.00K | $95.10K | New |
| Q2 2026 | 1.12M | $30.35M | New |
| Q3 2026 | 1.12M | $28.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MLYS and 13F data
MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MLYS
- RA CAPITAL MANAGEMENT, L.P. 7.69M sh · $207.55M · Q2 2026
- Catalys Pacific, LLC 7.80M sh · $196.00M · Q3 2026
- Samsara BioCapital, LLC 5.87M sh · $158.40M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.96M sh · $106.79M · Q2 2026
- Laurion Capital Management LP 2.48M sh · $62.37M · Q3 2026
- ORBIMED ADVISORS LLC 2.11M sh · $56.94M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.56M sh · $42.20M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.60M sh · $40.21M · Q3 2026
- Andera Partners 1.59M sh · $40.00M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.47M sh · $39.66M · Q2 2026
- Prosight Management, LP 800.00K sh · $20.10M · Q3 2026
- Affinity Asset Advisors, LLC 750.00K sh · $18.85M · Q3 2026
More on Ghisallo Capital Management LLC
FAQ
How long has Ghisallo Capital Management LLC held MLYS?
Ghisallo Capital Management LLC has disclosed MLYS holdings in 3 of the last 13 reported quarters, going back to Q3 2023.
What is Ghisallo Capital Management LLC's current position in MLYS?
As of Q3 2026, Ghisallo Capital Management LLC holds 1.12M shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $28.27M, representing 0.65% of its reported portfolio and ranking #24.
Has Ghisallo Capital Management LLC been buying or selling MLYS?
In the latest 13F filing (Q3 2026), Ghisallo Capital Management LLC held unchanged its position in MLYS. The position peaked in Q2 2026 at 1.12M shares.
Which other funds hold MLYS?
Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.